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 Intrauterine growth restriction (IUGR) is associated with impaired lung development and function.  Lung function is impaired in IUGR rats, in part, by altered surfactant composition.  The lipid profile in lungs determines surfactant lipid composition.  Our IUGR rats have decreased lung palmitoleic acid (16:1). Stearoyl CoA Desaturase (SCD), the rate‐limiting enzyme in synthesis of palmitoleic acid, is a target of transcription factor peroxisome proliferator activated receptor gamma (PPARγ) and is susceptible to transcriptional regulation through epigenetic modifications.  There are a number of genes in the lung that show altered mRNA levels in association with decreased PPARγ levels and epigenetic modifications in the presence of IUGR.  The effect of IUGR on the epigenetic profile of SCD as well as SCD mRNA and protein levels in the newborn rat lung is unknown.  We hypothesize 
that IUGR will be associated with reduced SCD mRNA and protein levels consistent with 
the previously observed decrease in PPARγ levels in the lungs of d0 rat pups.  We further 
hypothesize that there will be gender-specific changes in the epigenetic profile along the 
length of the SCD gene.    
 This hypothesis was tested using a uteroplacental insufficiency (UPI) model of 
IUGR in rats.  Whole lung tissue was harvested at birth (d0) and used to assess SCD 
mRNA and protein levels by RT-PCR and western blot analysis.  Epigenetic 
 modifications (H3K14Ac and H3K36Me3) were assessed along the SCD gene using 
chromatin immunoprecipitation (ChIP).   
 Results showed that, in control lungs females have 153% higher SCD mRNA than 
males (p=0.005).  A consistent decrease in SCD mRNA levels was found in both male 
and female IUGR rats at birth relative to controls (p=0.009, p=0.0023).  H3K14Ac was 
increased at SCD exon 4 in IUGR females to 210% of the level detected in gender-
matched controls (p=0.037).  H3K3Me3 was decreased at SCD exon 4 in IUGR males by 
43% (p=0.044) and at SCD 3’UTR in IUGR females by 65% relative to gender-matched 
controls (p=0.036).  There was no change in SCD protein levels in IUGR rats at birth.  In 
conclusion IUGR is associated with decreased SCD mRNA levels and gender-specific 
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Intrauterine Growth Restriction   
Intrauterine growth restriction (IUGR) is a condition affecting 5-12% of preterm 
infants born in the United States(1).  These children not only fail to reach their genetic 
growth potential adjusted for gestational age but are also at an increased risk of premature 
delivery as well as postnatal morbidities and mortalities(2).  Growth restricted infants 
have a 10-fold increased rate of death at term(3).  IUGR can result from fetal 
development in an environment of uteroplacental insufficiency (UPI) caused by maternal 
malnutrition, restricted blood flow to the uterus or toxin exposure.  In developed 
countries, IUGR is most often associated with conditions of restricted maternal blood 
flow such as preeclampsia(4).  Preeclampsia is a significant occurrence in pregnant 
women affecting 5-10% of pregnancies in the United States (5).  Regardless of the cause, 
the postnatal effects of IUGR persist throughout the lifecycle and impact a wide range of 
systems including lung development and function.   
 
Lung Phenotype of IUGR  
Although previous research has been heavily focused on the metabolic 
consequences of IUGR, recent attention has been drawn to the phenotypes observed in 





increased risk of poor lung development and morbidity due to pulmonary 
complications(2).  Population-based studies have concluded that IUGR infants, carried to 
term, require increased ventillary support (6) and pre-term IUGR infants are at an 
increased risk of developing respiratory distress syndrome (RDS)(7) as well as 
bronchopulmonary dysplasia  (BPD) (8, 9) early in life.  These implications of IUGR are 
seen in both male and female infants; however, studies have shown that males are more 
severely affected than females(10, 11).  Symptoms of impaired lung function persist into 
adulthood in both term and preterm infants(12).   
In animal models of IUGR, impaired alveolar development has been identified as 
a contributing factor to lung disease by impairing the efficiency of gas exchange in the 
lungs(13-15).  IUGR alters characteristics of the developing lung structure that are crucial 
to proper alveolar formation (16).   Such characteristics are also associated with the 
phenotype of BPD in animal models(17, 18).   
Lung function and development is also disrupted in IUGR animals through 
impaired surfactant composition and synthesis.   Phospholipids, the most significant lipid 
component of surfactant, have recently been identified as an additional target for IUGR 
induced changes in fetal phenotypes. The predominant phospholipid in surfactant is 
dipalmitoyl phosphatidyl choline (DPPC), which is a phosphatidyl choline molecule with 
two palmitic acid molecules attached. Changing surfactant composition changes its 
physiologic properties(19). Lungs of IUGR rat pups have significantly decreased 
compliance at birth, a phenotype that may be associated with altered surfactant(16).  
In addition, the lipid environment can affect physiologic lung function beyond 





characterized to date.  Lipids are known to affect functional properties by way of cell 
membrane fluidity and structure (20).  Fatty acids are additionally involved in many other 
cell functions important in pulmonary tissue such as binding of membrane-associated 
enzymes and hormone receptors, cell growth, cytotoxicity and second-messenger 
pathways(21, 22). Therefore, the fatty acid environment in lung tissue has the potential to 
affect not only lung development and function but also other physiological systems by 
way of communication mechanisms within cells and between cells. Understanding the 
effects of IUGR on lung lipid metabolism and composition will contribute to the evolving 
picture of the IUGR lung phenotype.  
Prior to this study, little was known about the effects of IUGR on the lipid profile 
and fatty acid metabolism in the lungs.  A study focusing on the effects of maternal 
nutrient restriction on fetal sheep demonstrated altered long chain polyunsaturated fatty 
acid (LCPUFA) levels in lung tissue(23).  Furthermore, our previous research 
demonstrated a significant change in the phospholipid profile of lung surfactant in our 
uteroplacental insufficiency-induced IUGR rat model.  Specifically the amount of DPPC 
present in the lungs of IUGR rats at birth is significantly lower than those of control 
rats(24).  Based on these findings we measured lung phospholipid content of newborn 
IUGR rat pups.   
 
Preliminary Data of this Project  
We collected preliminary data demonstrating that the lungs of d0 IUGR rats had 
altered lipid profiles.  IUGR altered the levels of palmitoleic acid found in whole lungs of 





lung tissue (80% of controls in males & 75% of controls in females p<0.05)(Figure 1). 
 Interestingly, no change was seen in the levels of the lipid precursor to palmitoleic 
acid, palmitic acid in the lungs of d0 IUGR rat pups (16:0).  This data suggests that IUGR 
may interfere with the reaction of lipid metabolism responsible for the conversion of 
palmitic acid to palmitoleic acid.  The effects of IUGR on the lipid profile and the 
mechanism of lipid metabolism in the lungs of newborn rats remain unknown.   
 
Role of Stearoyl CoA Desaturase in Lung Development and Function    
The profile of phospholipids present in lung tissue is predominately determined 
by the type and relative concentrations of intracellular fatty acids.  The group of enzymes 
responsible for synthesizing many of the long chain fatty acids (LCFA) present in the 
lung is the desaturase enzymes. Delta-9 desaturase, also known as stearoyl CoA 
desaturase (encoded by the SCD gene) is an ideal target for studying an altered 
 
Figure 1.  Palmitoleic acid levels of d0 IUGR lungs relative to control lungs. Data 




































pulmonary lipid environment because of the specificity inherent to its function. This 
enzyme catalyzes the rate-limiting step in the conversion of palmitic acid to palmitoleic 
acid, the two most abundant fatty acids found in surfactant and in lung tissue as a whole.  
SCD is therefore a clear target for further studies on the effects of IUGR on the lipid 
environment in the lungs as well as the physiologic properties of surfactant.  
 
Transcriptional Regulation of Stearoyl CoA Desaturase  
The reaction catalyzed by SCD is an opportunity for disruption of lipid 
metabolism in the developing lungs of newborn IUGR rats.  One means of altering SCD 
levels in the lung is by changing the transcription of the SCD gene.  Two ways that SCD 
transcription can be modified are changes in the epigenetic profile of the gene and altered 
levels of one of its transcription factors, PPARγ.   IUGR has previously been associated 
with altered gene expression and epigenetic modification in lung tissue(24, 25).   
 
Epigenetics 
Epigenetic regulation of gene transcription is not static and responds to 
environmental cues.  IUGR affects transcriptional regulation in part by influencing 
enzymes that alter the epigenetic profile of specific target genes.  These enzymes induce 
phenotypic changes by placing specific epigenetic marks on the histone proteins 
associated with stretches of chromatin encoding target genes.  Epigenetic marks either 
individually or together in concert alter interactions between the target gene and the 
transcription machinery.  Our lab has previously shown that IUGR is associated with 
gender-specific changes in the epigenetic profile and subsequent mRNA levels of genes 





Of the four histone proteins present in each nucleosome unit, H2A, H2B, H3, and 
H4 this project focused on modifications made to H3 (Figure 2).  The two modifications 
detected in this project are tri-methylation at lysine 36 (H3K36Me3) and acetylation at 
lysine 14 (H3K14Ac).  These epigenetic modifications exhibit gender-specific changes in 
our IUGR model and have been associated with altered mRNA levels of target genes 
(27).   
 
PPARγ   
   In addition to epigenetic modifications, one opportunity for direct regulation of 
SCD transcription is through binding of the transcription factor, peroxisome proliferator 
activated receptor gamma (PPARγ). The SCD gene contains a PPARγ response element 
(PPRE) in its promoter region and is up regulated by elevated PPAR levels (α, β, and γ) 
in the liver of rats(28).  
PPARγ plays a significant role in the phenotype of impaired lung development 
that is associated with IUGR.  PPARγ-knockout mice have impaired lung development 
and function due to enlarged airspaces, increased lung volumes, and decreased tissue 
resistance(29).  This phenotype has also been associated with altered transcription of 
 
Figure 2. Map of epigenetic modifications identified along the N-terminus of H3, 






mesenchymal genes known to be targets of transcriptional regulation by PPARγ(29).  
Furthermore, PPARγ plays a crucial role in the parathyroid hormone related protein 
(PTHrP)-driven epithelial-mesenchymal paracrine loop that is critical to lung 
development(30).  IUGR decreases mRNA and protein levels of PPARγ in newborn 
rat lungs(25).  Furthermore, the transcription factor has been associated with altered 
transcriptional regulation of genes in the lungs of IUGR rats(25, 26).  Despite our current 
knowledge that PPARγ mRNA and protein levels are decreased in IUGR and SCD 
activity is responsive to alterations in PPARγ concentration, we do not know the effects 
of IUGR on the desaturase enzyme or on lipid metabolism in lung tissue.    
 
Hypothesis    
In an effort to further characterize the effects of IUGR on fatty acid metabolism in 
the lung, this project focused measuring the levels of Δ9 desaturase mRNA and protein 
present in IUGR lung tissue compared to lung tissue from a non-IUGR controls as well as 
assessing the profile of epigenetic modifications that may be altering SCD transcription 
in the lungs of d0 IUGR rats. We hypothesize that IUGR will decrease SCD mRNA 
and protein levels consistent with the previously observed decrease in PPARγ levels 
in the lungs of d0 rat pups.  We further hypothesize that there will be gender-











This project used the rat uteroplacental insufficiency model. This model is a well-
established rat-model that induces IUGR by reducing fetal blood through uteral artery 
ligation on day 19 of gestation (full term is 21.5 days)(25, 31).  The surgical procedures 
have been previously described in detail (32, 33).  This procedure reduces fetal blood 
supply to a level that mimics the fetal conditions present during human UPI and induces 
IUGR in the pups(34).  Our lab has extensive experience with this model, which provides 
insight into the effects of IUGR on alveolarization, a critical stage of pulmonary 
development that is typically occurring pre-birth in humans.    
In this project, each experimental group originated from pregnant Sprague-
Dawley rats that were housed individually under standard conditions with 12-hour 
light/dark cycles.  The animals were randomly assigned to undergo UPI treatment or 
control.  At d19 of gestation, the UPI intervention rats were anesthetized with 
intraperitoneal xylazine (8mg/kg) and ketamine (40mg/kg), and both inferior uterine 
arteries were ligated.  The non-UPI control rats were subjected to an identical anesthesia 
without the surgical procedure.   
One to two pups from six dams were assigned to each experimental group to 
assure that isolated tissues incorporate appropriate litter-to-litter variation.  IUGR pups 





birth (31).  On day zero (d0) the pups were delivered through caesarian section and 
euthanized using a sodium pentobarbital overdose (150 mg/kg).  Serum was collected and 
lung tissue was immediately harvested and flash frozen in liquid nitrogen.   
 
Real-Time RT PCR  
This project utilized techniques of real-time reverse transcriptase PCR to quantify 
the amount of Δ9 desaturase mRNA present in lung tissue. Total mRNA was extracted 
from lung tissue using a “NucleoSpin RNA II” RNA extraction kit according to 
manufacturer’s protocol. Total RNA was quantified and 1 µg was used to synthesize 
cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 
Foster CA).  An assay-on-demand primer/probe set for SCD was used.  GAPDH was 
utilized as the control.   
All real-time PCR amplification, data acquisition and analysis was done using the 
7900HT Real-time PCR system and SDS Enterprise Software (Applied Biosystems) 
using a 384-Well Optical Reaction Plate (Applied Biosystems) at the University of Utah 
genomics core facility.  Taqman Universal PCR Mastermix (Applied Biosystems) was 
used in a 6 µL reaction, and performed in quadruplicate.  Cycle parameters were: 50°C x 
2 min, 95 °C x 10 min, followed by 40 cycles of 95°C x 15 sec and 60°C x 60 sec.   
 
Protein Quantification  
Lung tissue levels of Δ9 desaturase protein were quantified using western 
blotting.  Lung tissue proteins were isolated using homogenization in RIPA buffer (50 





SDS) and protease inhibitor cocktail (Roche-Complete Mini), followed by 
centrifugation at 10,000g, 4°C, 15 minutes.  Samples were assayed in triplicate for 
protein concentration using the bicinchoninic acid protein assay kit (Pierce).  Western 
blotting was performed using standard procedures, with the following specifics; samples 
containing 100 µg total protein were run on 10% bis-tris XT Criterion gels (Bio-Rad 
Laboratories), PVDF membranes were blocked in 3% BSA-TBST and incubated with an 
anti-SCD primary antibody. Following incubation with anti-mouse secondary antibody, 
signal was determined using enhanced chemiluminescence (ECL) according to the 
manufacturer’s instructions (Amersham, Little Chalfont, UK).   
 
Chromatin Immunoprecipitation (ChIP)  
Chromatin immunoprecipitation (ChIP) was used to detect the presence of histone 
modifications at three sites along the length of the SCD gene: the promoter, exon 4, and 
3’ UTR (Figure 3).  Experiments followed a revised protocol based on the methods of 
Farnham and Bomstztyk(35, 36).  Chromatin was isolated from whole lungs of male and 
female rat pups as follows; tissue was fixed in 1% formaldehyde for 10 minutes at room 
temperature, followed by the addition of glycine to a concentration of 125 mM to stop the 
reaction.  Samples were washed and re-suspended in PBS with protease inhibitor cocktail 
(PIC) at the concentration recommended by the manufacturer (Complete, Mini. Roche, 
Indianapolis, IN).  After centrifugation, cell pellets were re-suspended in lysis buffer 
(5mM PIPES, pH 8.0, 85 mM KCL, 0.5% Igepal) with PIC and dounced on ice using a 
tight pestle.  After centrifuging, pelleted nuclei were re-suspended in nuclei lysis buffer 






ice and split into aliquots of approximately 200 ul in (1.5 mL tubes) for sonication.  
Sonication was performed on ice using a Fisher Scientific Moel 100 sonicator with micro 
tip attachment (Fisher Scientific, Pittsburg, PA).  Each sample was pulsed 10 times with 
the microtip placed near the base of the tube and returned to ice, this was repeated a total 
of 10 times.  After centrifuging, chromatin containing supernatants for each of the four 
experimental groups (male SHAM, male IUGR, female SHAM, and female IUGR) were 
frozen at -80°C.   
Immunoprecipitation (IP) was performed as previously described using anti-
H3K36Me3 antibody (Abcam, ab9050-100), and anti-H3K14Ac (Milipore, 
DAM1548623)(25).  Levels of the two epigenetic marks present at a non-transcribing 
intergenic region were used as a control (27).  Table 1 contains primer and probe 











Figure 3. SCD Gene Structure.  The 3 probe/primer sets (indicated by the dashed 
lines) used in the ChIP protocol were located at the promoter (P), exon 4 (4), and the 








Table 1. Primer/probe sets for ChIP analysis. 
Primer/Probe Sequence 
SCD Promoter 
    Forward primer 
    Reverse primer 





SCD Exon 4 
    Forward primer 
    Reverse primer 






    Forward primer 
    Reverse primer 









Data are presented as means ± standard deviation.  Statistical significance was 
determined using ANOVA and student’s unpaired t-test using the Statistix 8 software 
package (Analytical Software, Tallahasse, FL) p < 0.05 was accepted for statistical 









Gender-specific SCD mRNA levels in control rats 
  
There is a gender-specific difference in SCD mRNA levels of control rat lungs at 
d0 (Figure 4).  SCD mRNA levels were approximately 153% higher in the lungs of 
female control rats when compared to the lungs of male control rats at birth (p=0.005).   
 
Epigenetic profile in male and female control rats   
 H3K14Ac and H3K36Me3 were detectable across the length of the SCD gene.  A 
similar epigenetic profile was detected in both modifications showing increased levels of 
both marks at exon 4 compared to the promoter or the 3’ UTR.  There was no significant 
gender-specific difference detected in the amount of H3K36Me3 or H3K14Ac in male 
and female control rats at d0 (Figure 5a and 5b).   
 
Figure 4. SCD mRNA levels in male and female control rat lungs at d0.  (mean ± 

































































































Effect of IUGR on SCD mRNA levels 
  
 IUGR decreased SCD mRNA levels at birth in males (p=0.0099) and females 
(p=0.0023) (Figure 6).  There were no gender-specific differences in the effects of IUGR 
on SCD mRNA levels in d0 lungs.   
 
Epigenetic profile along the SCD gene  
Effect of IUGR on H3K14Ac   
We used ChIP to determine the epigenetic profile along the SCD gene in lung 
tissue of male and female rats at d0.  H3K14Ac was detectable across the length of the 
SCD gene at birth in male and female IUGR and control rat lungs (Figure 7a and 7b).  
IUGR had a gender-specific effect on H3K14Ac levels along the SCD gene.  There was 
no change in H3K14Ac seen along the SCD gene in male rat pups, however IUGR 
increased levels of H3K14Ac in the 3’UTR region of SCD in the lungs of female rats at 
d0 to 211% of the level observed in controls (Figure 7b, p=0.037).   
* *  *p<0.05 
 
Figure 6. SCD mRNA levels in d0 IUGR lungs relative to controls.  Data represented 









































Figure 7. H3K14Ac along the SCD gene in d0 lungs of IUGR rats relative to controls 
(a. males, b. females).  Data presented as H3K14Ac levels in IUGR as a percent of 
control levels at the promoter, exon 4, and 3' UTR ± standard deviation (*p=0.037).  
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Effect of IUGR on H3K36Me3   
H3K36M3 was detectable across the length of the SCD gene at birth in the lungs 
of male and female control animals (Figure 8a and 8b).  There was a gender-specific 
change in tri-methylation across the SCD gene associated with IUGR.  IUGR decreased 
H3K36Me3 at the exon 4 of SCD in males by 43% (p=0.036) and at the 3’UTR of 




Figure 8. H3K36Me3 along the SCD gene in d0 lungs of IUGR rats relative to controls (a. 
males, b. females).  Data presented as H3K36Me3 levels in IUGR as a percent of control 































IUGR has no effect on SCD protein levels in lung tissue at d0  
Contrary to SCD mRNA levels, there was no statistically significant difference in 
SCD protein levels detected between IUGR and control lungs in neither male (p=0.25) 







Figure 9. Analysis of SCD protein levels in d0 lungs of IUGR rats relative to controls (a. 
SCD protein levels represented as a percent of control ± standard deviation, b. western 
blot of SCD protein in d0 lungs of IUGR and control rats, MI = male IUGR, MS = male 































In this study we gained valuable insight into the potential mechanisms leading to 
altered lipid metabolism in the lungs of IUGR rats.  The primary finding of this study is 
that IUGR alters the epigenetic profile along the SCD gene in a gender-specific manner. 
This is accompanied by a decrease in SCD mRNA levels in the lungs of newborn male 
and female IUGR rats compared to control rats.  Despite decreased levels of SCD 
mRNA, we did not detect a statistically significant change in SCD protein levels in IUGR 
pups at d0 when compared to controls.   
One striking aspect of IUGR seen in both human and animal models is the 
gender-specificity observed in many of the health implications throughout the lifespan.  
IUGR males most commonly fair worse than females(10, 11).  The findings of this study 
were often, but not exclusively, gender-specific as well.  The level of SCD mRNA 
detected in control rats at d0 was 153% higher in females than in males, however, this 
was not accompanied by any gender-specific difference in the epigenetic profile along the 
SCD gene.  These findings lead us to speculate that this observation is associated with the 
differential timing of lung development seen in male and female rats.  Specifically, 
female rat lungs are at a slightly advanced developmental stage when compared to males 
at birth and this has been noted to affect gene transcription and surfactant synthesis(37, 





A notable gender-specific effect of IUGR in this study, was alterations to the 
epigenetic profile along the SCD gene.  We observed an increase in H3K14Ac at two 
different locations along the SCD gene in lungs of male and female rats at d0, exon 4 and 
in the 3’UTR respectively.  Additionally, H3K36Me3 was only decreased at exon 4 in the 
SCD gene of IUGR males at d0.  It is generally well accepted that increased H3K14Ac 
and H3K36Me3 is associated with increased gene expression (27, 39).  Despite this 
association, our results demonstrated gender-specific increases in H3K14Ac and 
decreases in H3K36Me3 and a net decrease in SCD mRNA levels in the lungs of both 
male and female IUGR rats at birth.  This finding highlights the importance of epigenetic 
modifications working in concert with each other to have a net effect on gene expression.  
Although there is an important association between altered epigenetic modifications and 
altered gene transcription in IUGR, it is unknown whether epigenetics is a causative 
factor in regulating these changes in gene expression or simply a marker of altered gene 
expression.  Regardless of its role in regulating gene expression, studies such as this one 
have allowed us to deepen our understanding of the implications of IUGR on a molecular 
level.    
Finally, our observed levels of SCD protein in IUGR lungs at birth compared to 
control lungs were contrary to what was expected.  We expected to see a decrease in 
mRNA and protein levels consistent with our preliminary findings of decreased 
palmitoleic acid levels; however, we observed a decrease in SCD mRNA levels and no 
change in SCD protein levels in IUGR.  This could be attributed, in part, to variability in 
the detection of protein levels through western blot analysis.  Additionally, decreased 





decreased protein abundance.  An investigation of SCD enzymatic activity would be 
a valuable addition to the findings presented in this study.   
 
Limitations  
The primary limitation in this study was the inability to detect levels of PPARγ at 
the SCD promoter.  Despite multiple attempts, technical difficulties prevented us from 
successfully completing ChIP with our anti-PPARγ antibody.  This is an important piece 
of data that would contribute to the findings of this study by demonstrating an alteration 
in  PPARγ occupancy of the SCD promoter.   
Although transcriptional regulation, mRNA levels and protein levels are 
important indicators of altered SCD presence in the lungs, this study was not a 
comprehensive assessment of interference in the catalysis of the conversion of palmitic 
(16:0) acid to palmitoleic (16:1) acid because we did not include a measure of SCD 
enzyme activity.  Enzymatic activity is a prominent opportunity for molecular 
interference in fatty acid metabolism and the subsequent lipid environment in the lung, 
however due to a limited timeframe it was not included in this project.   
Additionally, total lung tissue was utilized in these experiments and therefore 
there will be no distinction of free fatty acids from phospholipid fatty acids.  Given the 
strong correlation between levels of free fatty acids and the fatty acids incorporated into 
phospholipids, however, we do not perceive that this has greatly influenced our data.  
One final consideration is the inherent shortcomings of utilizing a rat model to study a 
human condition.  This particular rat model, however, is well characterized and mimics 





study late stages of pulmonary development without the added complications of pre-
term delivery.   
 
Future Research  
The findings of this study can be used to direct future research that will further 
elucidate the mechanisms of altered lung development and function in conditions of UPI-
induced IUGR.  Further elucidating the transcriptional regulation of SCD in the IUGR 
environment will shed light on potential interventions for the previously described 
pulmonary consequences of IUGR.  Specifically, we plan to pursue investigating the 
effects of ligand-mediated activation of PPARγ on SCD levels and subsequent measures 
of lung function such as surfactant composition and compliance.  Previous research has 
shown that polyunsaturated fatty acids (PUFA) can affect fatty acid metabolism by way 
of regulating gene expression.  When supplemented in maternal diets, docosahexaenoic 
acid (DHA) induces a restorative effect that counters the consequences of IUGR on 
PPARϒ and Setd8 expression in lung tissue(25).  Furthermore, studies in a tropical 
euyhaline fish model have shown that dietary PUFA’s alter desaturase expression 
independent of development in a growth restricted environment (40).  These studies 
indicate that there is strong rationale for observing the effects of DHA supplementation 
on desaturase expression in IUGR lung tissue.  Based on previous findings that 0.1% 
DHA diet ameliorate the consequences of IUGR on PPARγ and Setd8 expression in lung 
tissue, I would propose that preliminary studies focus on the effects of 0.1% DHA diet on 
the lung lipid profile as well as SCD mRNA and protein levels in the lungs of newborn 






The results of this study are a valuable addition to the body literature regarding 
fetal origins of adult disease.  To date, researchers have elucidated only part of the 
phenotype associated with IUGR infants.  By analyzing the levels of SCD mRNA and 
protein as well as the epigenetic modifications along the SCD gene, this study produced 
novel findings regarding the association between mRNA levels and epigenetic 
modifications in the presence of IUGR as well as the gender-specificity these 
implications.  Further elucidating the regulation of lipid metabolism in lung tissue of 
IUGR infants has established a foundation for future research to deepen the 
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